David R Epstein Insider Trades & Stock Holdings
David R Epstein, Director at AgomAb Therapeutics NV has 4 Form 4 trades on file since Oct 5, 2026. Open-market activity: 4 purchases ($219.65K) and 0 sales ($0), net +$219.65K. Latest filing: acquired 10K shares of $AGMB on Oct 21, 2026 at $8.88.
- Trades on file
- 4
- Open-market bought
- $219.65K
- Open-market sold
- $0
- Net open-market
- +$219.65K
- Shares held ($AGMB)
- 25K
- Latest filing
- Oct 21, 2026
Shares held by David R Epstein
Shares owned after the most recent Form 4 for each company.
All insider trades by David R Epstein
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $AGMB | Buy (Open-market buy) | 10K | $8.88 | $88.80K | 25K | +66.67% | Director | SEC | Read | ||||
| $AGMB | Buy (Open-market buy) | 5K | $8.90 | $44.50K | 15K | +50% | -9.7% | Director | SEC | — | |||
| $AGMB | Buy (Open-market buy) | 5K | $8.70 | $43.50K | 10K | +100% | -0.3% | Director | SEC | — | |||
| $AGMB | Buy (Open-market buy) | 5K | $8.57 | $42.85K | 5K | +4.6% | Director | SEC | — |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks David R Epstein traded
Frequently asked questions
Has David R Epstein been buying or selling stock?
David R Epstein has 4 open-market purchases and 0 open-market sales on file, net +$219.65K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was David R Epstein's latest insider trade?
acquired 10K shares of $AGMB on Oct 21, 2026 at $8.88.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Reply STOP anytime.
SMS Terms
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.